CAS 1818428-24-8

Fórmula: C28H35NO3

InChI: InChI=1S/C28H35NO3/c1-5-6-8-13-22-25(29-17-20-11-9-7-10-12-20)27(31)24(28(32)26(22)30)23-16-19(4)14-15-21(23)18(2)3/h7,9-12,16,21,23,29,31H,2,5-6,8,13-15,17H2,1,3-4H3/t21-,23+/m0/s1

Chave InChI: CGGGAXJIRQSRPH-JTHBVZDNSA-N

SMILES: CCCCCC1=C(C(=C(C(=O)C1=O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O)NCC3=CC=CC=C3

EHP-101

CAS: 1818428-24-8

EHP-101 is a PPARγ/CB2 dual agonist with anti-inflammatory properties, inhibits fat formation, and combats diet-related obesity.

Fórmula: C₂₈H₃₅NO₃

Pureza: 98.36%

Cor e Forma: Solid

Peso molecular: 433.58

Ref: TM-T13289

EHP-101

CAS: 1818428-24-8

EHP-101

Fórmula: C₂₈H₃₅NO₃

Pureza: ≥98%

Peso molecular: 433.58

Ref: 54-BUP04499

Etrinabdione

CAS: 1818428-24-8

Pureza: 98%

Ref: IN-DA01V435

EHP-101

CAS: 1818428-24-8

EHP-101 is a synthetic cannabinoid that binds to the CB2 receptor. It has been shown to have anti-inflammatory effects and may be useful for the treatment of skin cancer, atp levels in cardiac cells, and microglia activation. This drug has also been shown to stimulate collagen production and inhibit neuronal death. Clinical studies have shown that EHP-101 can be used to treat inflammatory diseases such as Crohn's disease and ulcerative colitis.

Fórmula: C₂₈H₃₅NO₃

Pureza: Min. 95%

Peso molecular: 433.6 g/mol

Ref: 3D-TXC42824